“…Glucocorticoids have been used as part of the treatment approach in virtually all AOSD studies so far [3, 4, 14, 17, 22, 25-27, 46, 56, 63, 66, 71, 80, 82, 87, 90, 91, 94, 103, 105, 107, 110, 117, 118, 124, 125, 140, 141, 144, 147, 148, 150-153, 158, 163, 166, 168, 170, 176, 182, 187, 190, 191, 193, 196, 199, 203, 205, 207, 208, 210, 215]. Their effectiveness has been reported to be higher than that of NSAIDs, with a range of 38-95% [60,66,67,90,151,171,191], albeit with a high risk of flare after discontinuation [141,144,151]. The use of glucocorticoids is therefore recommended as part of an initial treatment regime in AOSD [3, 4, 7, 14, 17, 22, 25-27, 46, 56, 63, 66, 71, 80, 82, 87, 90, 91, 94, 103, 105, 107, 110, 117, 118, 124, 125, 140, 141, 144, 147, 148, 150-153, 157, 158, 163, 166, 168, 170, 171, 175, 176, 182, 187, 190, 191, 193, 196, 199, 203, 205, 207, 208, 210, 215] (see recommendation 9 in .…”